Progress in the field of precision medicine has changed the landscape of cancer therapy.
Precision medicine is propelled by technologies that enable molecular profiling, genomic …

Every year, cancer is responsible for millions of deaths worldwide and, even though much
progress has been achieved in medicine, there are still many issues that must be addressed …

Recent progress in protein-based nanomedicine, inspired by the success of Abraxane®
albumin-paclitaxel nanoparticles, have resulted in novel therapeutics used for treatment of …

Natural compounds have significant anticancer pharmacological activities, but often suffer
from low bioavailability and selectivity that limit therapeutic use. The present work critically …

Lung cancer is the leading cause of cancer‐related mortality both in men and women and
accounts for 18.4% of all cancer‐related deaths. Although advanced therapy methods have …

Introduction: The use of herbal compounds in cancer therapy has great potential to promote
the efficacy of current cancer therapeutic strategies. Herbal compounds were successfully …

A successful drug delivery to a specific site relies on two essential factors including; efficient
entrapment of the drug within the carrier and successful delivery of drug-loaded nanocarrier …

Combination therapy offers promising opportunities for treating advanced non-small cell
lung cancer (NSCLC). Here, we established a chitosan-based nanocomplex CE7Q/CQ/S to …

Cancer cells normally develop the ability to rewire or reprogram themselves to become
resistant to treatments that were previously effective. Despite progress in understanding …

Cancer nanomedicines and the development of state-of-the-art multifunctional lipid-based
nanoparticles (NPs) has become a fundamental resource in resolving challenging …